Head-to-head · Cost-Efficiency Index
WeightRx vs Voxy
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
WeightRx
Shoppers chasing the lowest published tirzepatide figure who are willing to finish intake before reading the plan terms.
Visit WeightRxVoxy
Shoppers who want to know exactly which pharmacy and medical group stand behind their prescription, with a simple all-in monthly price.
Visit VoxyThe verdict
WeightRx and Voxy tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers, so choose on fit. WeightRx: Shoppers chasing the lowest published tirzepatide figure who are willing to finish intake before reading the plan terms. Voxy: Shoppers who want to know exactly which pharmacy and medical group stand behind their prescription, with a simple all-in monthly price.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs WeightRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | WeightRx | Voxy |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $250/moCompounded | $175/moCompounded, billed monthly; $99/mo on a 12-month plan |
| Tirzepatide / mo | $83/moTerm not published, compounded | $225/moCompounded, billed monthly; $135/mo on a 12-month plan |
| Semaglutide / yr (modeled) | $3,000 | $2,100 |
| Tirzepatide / yr (modeled) | $996 | $2,700 |
| Coverage | Coverage not published | Not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #137 | #139 |
WeightRx
69/100Where the value is
- The tirzepatide figure is published up front, and it is genuinely low against the field
- Both molecules are offered
- No membership charge is advertised alongside the medication rate
The tradeoffs
- The $83 monthly rate is advertised as '$83/month ($997/year)', which is twelve months of it — no month-to-month rate is separately published, and the terms state that a rate is locked for its full term
- Both product pages linked from the homepage are broken, so you can't read the plan terms before intake
Voxy
69/100Where the value is
- Names its compounding pharmacy (VialsRX in Houston) and its prescribing medical group (Arora Health & Aesthetics) on a public compliance page
- One price includes the provider visit, medication, injection supplies, free shipping and monthly check-ins with dose adjustments
- Full price tables for 1-, 3-, 6- and 12-month plans are shown before you start
The tradeoffs
- The "starting at $99" and "$135" figures are 12-month plans billed annually; month to month it's $175 and $225
- Final pricing is confirmed at checkout after the assessment
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.